无关供者造血干细胞移植治疗合并侵袭性真菌感染的急性白血病2例并文献复习

张莉, 周健, 张龑莉, 等. 无关供者造血干细胞移植治疗合并侵袭性真菌感染的急性白血病2例并文献复习[J]. 临床血液学杂志, 2019, 32(1): 52-54. doi: 10.13201/j.issn.1004-2806.2019.01.014
引用本文: 张莉, 周健, 张龑莉, 等. 无关供者造血干细胞移植治疗合并侵袭性真菌感染的急性白血病2例并文献复习[J]. 临床血液学杂志, 2019, 32(1): 52-54. doi: 10.13201/j.issn.1004-2806.2019.01.014
ZHANG Li, ZHOU Jian, ZHANG Yanli, et al. Unrelated donor hematopoietic stem cell transplantation for acute leukemia with invasive fungal infection:Two cases report and literature review[J]. J Clin Hematol, 2019, 32(1): 52-54. doi: 10.13201/j.issn.1004-2806.2019.01.014
Citation: ZHANG Li, ZHOU Jian, ZHANG Yanli, et al. Unrelated donor hematopoietic stem cell transplantation for acute leukemia with invasive fungal infection:Two cases report and literature review[J]. J Clin Hematol, 2019, 32(1): 52-54. doi: 10.13201/j.issn.1004-2806.2019.01.014

无关供者造血干细胞移植治疗合并侵袭性真菌感染的急性白血病2例并文献复习

详细信息
    通讯作者: 宋永平,E-mail:songyongping@medmail.com.cn
  • 中图分类号: R733.71

Unrelated donor hematopoietic stem cell transplantation for acute leukemia with invasive fungal infection:Two cases report and literature review

More Information
  • 加载中
  • [1]

    中国侵袭性真菌感染工作组.血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则 (第四次修订版)[J].中华内科杂志, 2013, 52 (8):710-711.

    [2]

    Maziarz RT, Brazauskas R, Chen M, et al.Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies:a CIBMTR study[J].Bone Marrow Transplant, 2016, 52:270-278.

    [3]

    Liu Q, Lin R, Sun J, et al.Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis[J].Biol Blood Marrow Transplant, 2014, 20:1198-1203.

    [4]

    Azik FM, Tezer H, Parlakay AO, et al.Secondary antifungal prophylaxis in pediatric hematopoietic stem cell transplants[J].J Pediatr Hematol Oncol, 2015, 37:19-22.

    [5]

    de Fabritiis P, Spagnoli A, Bartolomeo PD, et al.Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection[J].Bone Marrow Transplant, 2007, 40:245-249.

    [6]

    Lei G, Sun Y, Meng F, et al.Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China:a multicenter prospective observational study[J].J Hematol Oncol, 2016, 9:97.

    [7]

    Liu F, Wu T, Wang JB, et al.Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients[J].Transpl Infect Dis, 2013, 15:243-250.

  • 加载中
计量
  • 文章访问数:  255
  • PDF下载数:  86
  • 施引文献:  0
出版历程
收稿日期:  2017-03-04

目录